Introduction {#sec0001}
============

To date, stroke is reported to be one of the most common neurological complications of COVID-19 infection. Proposed mechanisms of cerebrovascular events include a pro-inflammatory state, endothelial dysfunction, and thrombosis in micro- and macro-vasculature.[@bib0001] ^,^ [@bib0002] Patients with COVID-19 infection may develop severe acute respiratory distress syndrome (ARDS) and require ECMO support as a life-saving measure, which is accompanied with risk of bleeding namely due to use of anticoagulation. Here, we present a case of hemorrhagic stroke in a patient with severe ARDS related to COVID-19 requiring ECMO.

Case Presentation {#sec0002}
=================

38-year-old, previously healthy man was admitted to our hospital with fever, cough, and shortness of breath. He tested positive for both parainfluenza-2 and COVID-19. CT chest showed bilateral diffuse reticulonodular infiltrates. Patient\'s respiratory status worsened requiring mechanical ventilation and eventually ECMO support with continuous heparin infusion.

Other forms of therapy included course of Hydroxychloroquine, Azithromycin, and a dose of Tocilizumab. Patient became encephalopathic and a brain CT demonstrated a 2.6 cm left sub-insular parenchymal hemorrhage ([Fig 1](#fig0001){ref-type="fig"} ). Brain CT angiography showed no vascular abnormalities. Neurological examination revealed mild right facial weakness and dysarthria. Continuous EEG monitoring showed generalized slowing without EEG seizures. Follow up brain CT demonstrated resolution of hemorrhage. Overall, patient showed significant clinical improvement.Figure 1Brain CT without contrast demonstrating left sub-insular intraparenchymal hemorrhage with surrounding vasogenic edema.Figure 1:

Discussion {#sec0003}
==========

Intraparenchymal hemorrhages have been reported with ECMO. Postulated mechanisms include disruption in hemostasis likely potentiated by concomitant anticoagulation during ECMO, a pro-inflammatory state, which in this case can also be attributed to COVID-19, and hemodynamic dysfunction with loss of cerebral perfusion autoregulation.[@bib0003]

Thus, there may be dual pathogenesis resulting in hemorrhage: 1) COVID-19 related vasculopathy with endothelial damage of small vessels perhaps making them more susceptible to rupture. 2) ECMO related bleeding risks as mentioned above.

We aim to shed light on hemorrhagic stroke as one of the major neurological complications of COVID-19 infection in patients on ECMO. In these patients, a low threshold should be maintained to evaluate for intracranial hemorrhage.
